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SUMMARY - Intracranial metastases from laryngeal carcinoma are rarely clinically diagnosed. 
To our knowledge, this is the first report of hypopituitarism due to pituitary metastasis from laryn-
geal carcinoma. We report on a 70-year-old man who had a supraglottic squamous cell carcinoma, 
which was resected surgically followed by local full dose radiation therapy. Four months later, he 
presented with a sudden onset of diplopia, syncope, headache, general malaise and loss of appetite. 
Magnetic resonance imaging of the brain revealed a tumorous process of the sellar region. Endo-
crinological tests disclosed the presence of hypopituitarism. The tumor was subtotally resected en-
doscopically via endonasal transsphenoidal approach. Histopathology of tumor specimens indicated 
squamous cell carcinoma. Tumors of the sellar and parasellar region as in the case presented may 
easily be confused with pituitary adenoma. Pituitary metastases should be considered on differential 
diagnosis of unusual pituitary tumors, especially in patients with as well as in those without a history 
of malignant disease.
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Introduction
Laryngeal carcinoma is the second most common 
type of head and neck cancer. Laryngeal carcinomas 
are mainly squamous cell carcinomas. The incidence 
of distant metastases with laryngeal carcinoma varies 
from 3.7% to 16%1. The most common sites of distant 
metastasis are the lungs followed by bone and liver. 
Intracranial metastases in patients with head and neck 
cancer are rarely clinically diagnosed. The incidence 
of pituitary metastasis with malignant tumors is 1% 
to 3.6%2-4. Breast cancer is the most common tumor 
to metastasize to the pituitary gland, followed by lung 
cancer4-6. Diabetes insipidus secondary to pituitary 
metastasis is a common manifestation but hypopitu-
itarism is rather rare7,8. We report on a 70-year-old 
man presenting with hypopituitarism secondary to 
pituitary metastasis from supraglottic laryngeal carci-
noma. To our knowledge, this is the first case reported 
in the literature. 
Case Report
History
Five months before, the patient was diagnosed with 
squamous cell carcinoma of the left aryepiglottic fold of 
the larynx, stage IV A (T4a, N2b, M0). Radical neck 
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dissection was performed, the tumor was partially re-
moved and residual tumor was left at the branching area 
of the common carotid artery. Local radiation therapy 
was administered in full dose. Four months later, he 
presented with a sudden onset of diplopia, syncope, 
headache, general malaise and loss of appetite. 
Diagnostic evaluation
The patient was examined by the neurologist in a 
private polyclinic. Magnetic resonance imaging (MRI) 
of the brain with contrast revealed irregularly enhanced 
tumorous process of the sellar region, measuring 
35×25×25 mm (Fig. 1). The mass extended upward to 
the suprasellar region without involvement of the optic 
chiasm. Based only on radiological findings, it was hard 
to determine the relationship between the mass and the 
cavernous sinus, but clinical picture suggested exten-
sion to the cavernous sinus. Two weeks later, the patient 
was admitted to our Department for further examina-
tions and treatment for the sellar mass lesion. The pa-
tient had constant diplopia, headache, general malaise, 
loss of appetite, nausea, vomiting, and had lost 25 kilo-
grams in the last 5 months. Neurological examination 
identified right sixth cranial nerve palsy and diplopia 
was reported in all directions. There was no evidence of 
lymphadenopathy. On abdominal examination, there 
was no hepatosplenomegaly and no palpable mass. 
Complete blood count, hepatogram and electrolytes 
were all within the reference values. Chest radiograph 
was normal. Endocrinological tests disclosed the pres-
ence of hypothyroidism, T3 0.972 (normal 1.1-2.8) 
nmol/L, T4 62.0 (normal 60-165) nmol/L, TSH 0.135 
(normal 0.4-4.0) mIU/L; hypogonadism, LH 1.0 (nor-
mal 1.5-5.0) IU/L, FSH 1.6 (normal 1.0-10.5) IU/L, 
testosterone <0.7 (normal 10.5-49.0) nmol/L, border-
line adrenal insufficiency, serum cortisol at 8 hours 189 
(normal 138-800) nmol/L, at 17 hours 114 (normal 
80-488) nmol/L, and free cortisol in urine 111 (normal 
72.5-372.0) nmol/24h. Prolactin level was also slightly 
elevated, 34.2 (normal 2.0-20.0) mcg/L, probably due 
to pituitary stalk compression. Diabetes insipidus was 
absent and the function of the posterior lobe of the pi-
tuitary gland was preserved. Based on these studies and 
after consultation with a neurosurgeon and radiologist, 
the tumor was considered to be a nonfunctional pitu-
itary adenoma. The patient was prepared for surgery 
and was transferred to Department of Neurosurgery.
Fig. 1. Magnetic resonance imaging of the brain, sagittal and coronal T1-weighted postcontrast image: expansive tumorous 
process of the sellar region, which infiltrates sphenoidal sinus, partially destroys dorsum sellae and clivus, and expands to the 
prepontine and suprasellar cistern.
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Treatment 
The patient underwent endoscopic tumor resec-
tion using the binostril endonasal transsphenoidal 
approach9. The posterior wall of the sphenoidal sinus 
was partially destroyed by the tumor mass. Extremely 
firm tumorous tissue was reduced using the endo-
scopic technique with a wide variety of endoscopic 
instruments; and the CUSA instrument was used for 
the first time in endoscopic technique. Intraoperative 
histopathology revealed squamous cell carcinoma and 
the operation was discontinued. After the surgery, 
the patient was transferred back to our Department 
for initiation of replacement therapy. Histopathology 
of tumor specimens confirmed squamous cell carci-
noma (Fig. 2). Transfer to Oncology Department was 
planned for palliative radiotherapy using linear accel-
erator.
Discussion
Patients with supraglottic carcinoma have a greater 
risk to be diagnosed with high-grade carcinoma than 
those with glottic carcinoma. This is due to fewer ini-
tial symptoms and denser lymphatic vascularity in the 
supraglottis. The risk of distant metastases in patients 
with laryngeal carcinoma significantly increases in 
high-grade carcinoma with advanced local and re-
gional extension of the tumor. Our patient also had 
an advanced stage of supraglottic laryngeal carcinoma 
with tumor extension to the hypopharynx and with 
metastases to the regional lymphatic nodes. Accord-
ing to Spector and Sessions, the incidence of distant 
metastases in patients with laryngeal carcinoma treat-
ed with curative intent, depending on the localization 
within the larynx, are as follows: glottic 4%; supra-
glottic 3.7%; subglottic 14%; and aryepiglottic fold 
16%1. The most common sites of distant metastasis are 
the lungs (58%) and bone (22%)10. Intracranial me-
tastases from laryngeal carcinoma are rarely clinically 
diagnosed. To our knowledge, this is the first report 
of hypopituitarism due to pituitary metastasis from 
laryngeal carcinoma.
The incidence of pituitary metastases on autopsy 
is between 1% and 3.6%4-6, and if parasellar region is 
included the incidence rises up to 27%11. Breast and 
lung carcinoma are the two most common forms of 
malignant tumors that metastasize to pituitary gland. 
Autopsy series and intraoperative histologic examina-
tions in palliative hypophysectomy have documented 
pituitary metastases in 6% to 29% of breast cancer pa-
tients11-14. Within the pituitary gland, metastases are 
distributed as follows: 57% of the lesions are localized 
to the posterior pituitary alone, 13% to the anterior 
pituitary alone, 12% to both lobes, and the rest to the 
capsule or stalk. The highest involvement of the pos-
terior pituitary is explained by direct arterial blood 
supply to neurohypophysis, whereas adenohypophy-
sis receives its blood supply from the hypophyseal 
portal system5. Based on autopsy findings, only 7% 
of pituitary metastases are symptomatic5. According 
to Morita et al., of all symptomatic patients 61% have 
diabetes insipidus, 47% anterior hypopituitarism, 39% 
headache, 33% visual deficits, and 25% ophthalmople-
gia15. All these symptoms except for diabetes insipidus 
are common in pituitary adenomas. The question is 
how to differentiate pituitary metastasis from pitu-
itary adenoma in patients with a history of malignant 
disease, but also in those in which pituitary metastasis 
is the initial symptom of a malignant disease. On au-
topsies of cancer patients, Max et al.  found that 3.6% 
of all pituitary lesions were pituitary metastases and 
1.8% were pituitary adenomas3. Pituitary metastases 
are more likely to produce visual deficits from supra-
sellar extension and from invasion of the cavernous 
sinus, due to invasiveness of tumors that metastasize 
to the pituitary16. The presence of diabetes insipidus 
also suggests pituitary metastasis7,15. In our case, the 
Fig. 2. H & E stained section (X400) shows poorly differen-
tiated squamous cell carcinoma islands.
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patient had no visual deficits and no signs of diabetes 
insipidus. Right sixth cranial nerve palsy was present, 
but radiological findings could not confirm cavernous 
sinus invasion. There are few imaging characteristics 
that can help in differentiating pituitary metastases 
from pituitary adenomas: thickening of the pituitary 
stalk, loss of a high-intensity signal from the posterior 
pituitary, isointensity on both T1- and T2-weighted 
MR images, invasion of the cavernous sinus, and 
sclerotic changes around the sella turcica. They can 
be helpful but are in no way specific for pituitary me-
tastases15,17,18. 
In conclusion, tumors of the sellar and parasellar 
region such as the present case are easily confused 
with pituitary adenomas. Metastases from tumors, 
including laryngeal carcinoma, to the pituitary gland 
are extremely rare. Despite their rarity, they should 
be considered on differential diagnosis of unusual pi-
tuitary tumors, especially in patients with, but also in 
those without a history of malignant disease.
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Sažetak
HIPOPITUITARIZAM UZROKOVAN METASTAZOM SUPRAGLOTIČNOG KARCINOMA LARINKSA 
U HIPOFIZU: PRIKAZ SLUČAJA
I. Kruljac, P. Šulentić, M. Cigrovski-Berković, V. Petrović, H.I. Pećina, V. Čerina, K. Houra, L. Pažanin i M. Vrkljan
Intrakranijske metastaze karcinoma larinksa se rijetko dijagnosticiraju. Prema našim spoznajama, ovo je prvi zabi-
lježeni slučaj hipopituitarizma uzrokovanog metastazom karcinoma larinksa u hipofizu. Prikazujemo slučaj muškarca u 
dobi od 70 godina kojemu je dijagnosticiran supraglotički planocelularni karcinom larinksa koji je kirurški uklonjen te je 
provedena lokalna radioterapija u punoj dozi. Četiri mjeseca kasnije javljaju se naglo nastale dvoslike, glavobolja, sinkopa, 
opća slabost i gubitak apetita. Učinjena je MR mozga te je otkriven tumorski proces selarne i paraselarne regije. Endo-
krinološkim testovima otkriveno je postojanje hipopituitarizma. Tumor je djelomice odstranjen endonazalnim transsfe-
noidnim pristupom. Patohistološki nalaz pokazao je planocelularni karcinom. Tumori selarne i paraselarne regije, kao u 
ovom slučaju, lako se zamijene za adenom hipofize. Metastaze u hipofizu bi trebalo razmotriti u diferencijalnoj dijagnozi 
neobičnih tumora hipofize, pogotovo u bolesnika s poviješću maligne bolesti, ali također i u onih bez nje. 
Ključne riječi: Novotvorine larinksa – komplikacije; Larinks – patologija; Metastaza novotvorine; Novotvorine hipofize – 
dijagnostika; Hipopituitarizam – etiologija; Prikaz slučaja

